The Promise of mRNA Vaccines: A Biotech and Industrial Perspective


Authors: N.A.C Jackson, K.E. Kester, D. Casimiro, S. Gurunathan and F. DeRosa

Journal: npj Vaccines

DOI: 10.1038/s41541-020-0159-8

Publication - Abstract

February 04, 2020

Vaccines Nucleic Acid Lipid Nanoparticles mRNA

Abstract

mRNA technologies have the potential to transform areas of medicine, including the prophylaxis of infectious diseases. The advantages for vaccines range from the acceleration of immunogen discovery to rapid response and multiple disease target manufacturing. A greater understanding of quality attributes that dictate translation efficiency, as well as a comprehensive appreciation of the importance of mRNA delivery, are influencing a new era of investment in development activities. The application of translational sciences and growing early-phase clinical experience continue to inform candidate vaccine selection. Here we review the state of the art for the prevention of infectious diseases by using mRNA and pertinent topics to the biotechnology and pharmaceutical industries.

limit search to this category
Advanced Search

Advanced Search

close
  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Articles
Search

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads


related content

Publication - Abstract

Sep 25, 2020
ACS Applied Nano Materials

Polysarcosine-Functionalized Lipid Nanoparticles for Therapeutic mRNA Delivery

S.S. Nogueira, A. Schlegel, K. Maxeiner, B. Weber, M. Barz, H. Haas et. al.

mRNA Nucleic Acid Lipid Nanoparticles Other Applications
Read More


Publication - Abstract

Nov 18, 2020
Science Advances

CRISPR- Cas9 Genome Editing Using Targeted Lipid Nanoparticles for Cancer Therapy

D. Rosenblum, A. Gutkin, R. Kedmi, S. Ramishetti, N. Veiga, A.M. Jacobi and D. Peer et. al.

mRNA Nucleic Acid Lipid Nanoparticles Oncology
Read More


Sign Up and Stay Informed
Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.
Sign Up